Looking to Buy a Home? Do This First
Buying a home is stressful enough without getting blindsided with a higher-than-expected rate on your mortgage — or outright rejection — due to a low credit score or errors on your credit report.
Even so, only half of recent home buyers said they checked their credit report early on in the homebuying process, according to a report released by Experian.
That can make for some nerve-wracked meetings with lenders. About a third of those surveyed said that their credit score surprised them, and a fifth of buyers said their score was lower than expected. Fourteen percent of homebuyers found something negative on their credit report that they didn’t know about.
Related: Why Your Credit Score Is the Most Important Number in Your Life
A low credit score can have costly consequences. A borrower with a FICO score of 760, for example, would pay $1,360 per month on a $300,000 loan, while a borrower with a score of 759 would pay $1,397 per month on the same loan. That difference will add up to more than $10,000 over the life of a 30-year mortgage.
Forty-five percent of future homebuyers surveyed by Experian said that they had delayed purchasing a home in order to work on their credit and qualify for better rates.
If your score is lower than expected, first check the report for errors and contact the credit bureaus about correcting them. If you’ve been dinged for a single missed payment, call your credit card company to see if it will remove the incident from your reports. Then focus on making on-time payments and paying down any high balances to get your debt-to-income ratio below 25 percent.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
